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Bis(5-amidino-2-benzimidazolyl)methane (BABIM) is a
synthetic aromatic amidine compound which has a num-
ber of important biochemical effects, including inhibi-
tion of a family of esteroproteases (trypsin, urokinase,
plasmin) previously linked to the complex process oftu-
mor invasion. Previous work has suggested that exoge-
nous natural protease inhibitors can block invasion oftu-
mor cells across basement membranes (BM) in vitro. The
authors studied the effect of BABIM on the human cell
line HT-1080 with the use of a quantitative in vitro am-
nion invasion assay system. They have verified the abil-
ity of these cells to grow in nude mice and metastasize
via the lymphatics or blood vessels on the basis of the
route ofadministration ofthe inoculum. Cells which were
able to actively cross the entire BM were trapped on filters
and counted by both brightfield microscopy and by beta
scintillation counting of cells whose DNA was labeled
with tritiated thymidine. In agreement with either count-
ing technique, BABIM, at a concentration of 10- M,
significantly inhibited invasion (P < 0.005) over the 7-
day course of the experiments. Under these conditions,
the inhibitor was nontoxic and did not alter the attach-
ment ofthe cells to the amniotic membrane. Furthermore,
a highly significant inhibition ofinvasion (P< 0.001) was
also demonstrated across a variation in molar concentra-
tion ofBABIM ofmore than 2 orders ofmagnitude. Most
remarkably, cells were initially inhibited in their ability
to invade in the presence of between 10-9 and 10' M
BABIM. Measurement ofType IV specific collagenase in
media from these cells shows a significant inhibition of
activity in the presence ofBABIM. These results suggest
two, not necessarily exclusive, alternative interpretations:
first, that inhibition ofthe proteolytic steps along the path-
way of activation ofbasement membrane degrading en-
zymes results in inhibition of invasion; second, that ar-
ginine directed esteroproteases may work in concert with
cellular collagenolytic metalloproteinases in the process
ofinvasion by human tumor cells through native matrix
barriers. (Am J Pathol 1986, 123:46-56)
IN ORDER for metastases to occur, tumor cells must
have the capacity to invade normal tissues, especially
capillary and lymphatic vascular spaces.1 Basement
membranes are a major barrier to metastatic spread,
because tumor cells must often invade across epithe-
lial/dermal basement membranes as well as vascular
basement membranes in both directions.2 Enzymatic
proteins and proteases, especially those intimately as-
sociated with the coagulation system, including plas-
min and plasminogen activator, have been strongly
linked to cell invasion (by both benign and malignant
cells) through extracellular matrices.38 Antibodies
directed against plasminogen activator have been shown
to inhibit human tumor metastasis from carcinomas.9
Plasminogen activator has recently been used as a
marker for neoplastic transformation in studies includ-
ing those utilizing flow cytometry,10'1' although with
mixed results.12
Natural collagenase inhibitors exist in higher organ-
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isms, including man and are found in the serum as well
as in the extracellular fluid.13-15 Furthermore, natural
inhibitors applied exogenously to experimental systems
have been shown to inhibit tumor cell invasion. 16 Thor-
geirsson et al have demonstrated a "450% decrease" in
invasion of malignant mouse reticulum cell sarcoma
cells by exposing the cells to natural inhibitors of both
serine proteinases and metalloproteinases. 7 Other ex-
perimental studies have yielded similar results."82" This
raises the hope that a variety of protease inhibitors may
block tumor invasion.
We have previously synthesized a series of aromatic
mono- and diamidines which may work in part through
a similar antiprotease mechanism.22"23 Twelve synthetic
amidino compounds were screened for their ability to
inhibit tumor invasion in vitro (unpublished results).
Using one of these, we have performed a series of ex-
periments testing the ability of a synthetic arginine-
directed esteroprotease inhibitor, bis(5-amidino-2-ben-
zimidazolyl)methane (BABIM), to inhibit the invasion
of HT-1080 human fibrosarcoma cells through living
human basement membranes, using an amnion in vitro
model system of invasion.24 Once tumor cells penetrate
the basement membrane in this model, they become
lodged in an underlying inert methyl cellulose filter. In
previous studies using this model, cells completely cross-
ing the basement membrane and lodging in the filters
were stained and counted with the use of standard
brightfield microscopy.25 26 Similar visual examination
of the traversed human fibrosarcoma cells was per-
formed in this study, but in addition, a long-term
tritiated thymidine cell labeling technique was utilized
which proved to be easier to perform and gave more
reproducible results. These studies were repeated after
the cells had been passaged through BALB/c/NIH
Swiss hybrid mice.
To verify that the inhibitory effects of BABIM were
due to inhibition of invasion, and not secondary to ei-
ther decreased cellular proliferation or altered attach-
ment to matrix, the kinetics of cell growth in the pres-
ence and absence of BABIM was also studied. Finally,
as a direct test of BABIM's ability to inhibit one of the
proteolytic enzymes linked to invasion, we examined
the ability of BABIM to alter the cell's production of




Human fibrosarcoma cells (HT-1080), originally de-
rived from a primary human acetabular bone tumor,27
were a gift from Dr. Judson J. Van Wyk, Department
of Pediatrics, University of North Carolina at Chapel
Hill. They were originally obtained from the Cell Cul-
ture Laboratory, University of California, Naval Bio-
sciences Laboratory, Naval Supply Center, Oakland,
California, and maintained in continuous culture at the
tissue culture facility of the Lineberger Cancer Research
Center, University of North Carolina at Chapel Hill.
The cells were grown at 37 C in 5%o CO/957o air in
100-mm tissue culture dishes (Falcon) with Dulbecco's
minimal essential medium (DMEM) supplemented with
10%o fetal bovine serum, 2 mM L-glutamine and peni-
cillin G (100 i/ml), streptomycin (100 jig/ml) and
Fungizone (5 jg/ml) (all supplied by the Lineberger
Cancer Research Center). This cell line contains the ac-
tivated oncogene N-ras located on Chromosome 1,28
produces tumors in nude mice, and has its tumorige-
nicity dependent upon chromosome dosage.29
Cell Proliferation Studies
To determine the effects of BABIM on cell growth,
1 x 105 HT-1080 cells were added to medium contain-
ing 50-mm tissue culture plates in the presence or ab-
sence of differing concentrations of BABIM. For one
series of experiments, the cells were initially incubated
in 100o fetal bovine serum-containing medium. This
was exchanged for serum-free medium after the first
day, thereby recapitulating the experimental conditions
in the upper chamber of the amnion invasion assay
chambers (as discussed below). Cell counts were per-
formed in triplicate every 24 hours for 7 days.
Amnion Invasion Assay System
Lucite amnion invasion assay chambers were custom-
made in the instrument shop of the Department of
Physics and Astronomy, University of North Carolina,
from a prototype provided by Dr. Lance A. Liotta, Lab-
oratory of Pathology, National Cancer Institute.30 The
design of the chamber and methods pertaining to its
use have been previously detailed by Russo et al.31
As modified by us, the amnion was prepared as fol-
lows: Blunt dissection was used to separate nonopaque
viable amnion from routinely delivered placentas which
were less than 18 hours old. The simple cuboidal epi-
thelium was removed by alkali treatment in 0.1 N am-
monium hydroxide. The orientation of the membrane
was retained, and the amnion holders were fitted with
the denuded side of the membrane up, which exposed
the basement membrane to the HT-1080 cells and
created an upper and lower chamber. A Millipore filter
(0.45 j) was placed beneath the membrane, in contact
with the stromal side, to catch cells able to transverse
the amnion.
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Prepared chambers were placed in six-well tissue cul-
ture trays (Falcon or Costar) containing approximately
1.5 ml of serum-containing medium, which filled the
bottom chamber. Under experimental conditions,
serum-containing medium remained in the lower cham-
ber throughout the experiment. At zero time, 5 x 105
harvested viable tumor cells were added to the upper
chamber in the presence of 10% FCS-containing
medium to enhance attachment of the cells to the am-
niotic basement membrane. Cell counts were performed
in triplicate in a Coulter counter after the cells were
washed in Hanks' balanced salt solution and exposed
to 0.25% trypsinization. Previous trypan blue exclu-
sion studies showed a viability greater than 97%Vo when
cells were prepared in this manner. After 24 hours, the
medium in the upper chamber was removed and
replaced with serum-free medium in the presence or ab-
sence of BABIM. Fresh BABIM-containing solutions
were replenished every other day.
Quantitation of Invading Cells
In all experiments three of the six wells on any one
tray contained medium with BABIM, and the other
three did not contain BABIM. For each experiment each
point of the time course was studied in triplicate. Inva-
sion in amnion holder containing trays was stopped at
Days 3, 5, and 7. One to two wells were prepared for
each experiment without filters, and a drop of India
ink was placed in the upper chamber so that we could
evaluate and verify that the amnion was free of defects.
Cells were measured for invasion by two different tech-
niques: direct visual counting or 3H-labeling of cells.
In the former, the invasion was terminated at the ap-
propriate times by fixation in 100/o buffered formalin;
the filters and amnion were stained with Mayer's
hematoxylin, separated, placed on glass slides, and de-
hydrated with graded ethanol and xylene. Immersion
oil was used to render the filters transparent. The
filters/amnion were coverslipped and the slides exam-
ined at x 400 on a Leitz brightfield microscope with
a mechanical stage. For the purpose of this study
clusters of cells were counted as a single cell. The
reproducibility and variability of this assay have been
documented previously.24
In duplicate experiments, HT-1080 cells, in the log
phase of growth, were long-term-labeled with methyl-
tritiated thymidine (1 iCi/ml) (ICN) and left 24 hours
before harvesting. At appropriate times the medium was
removed and the filters were allowed to air-dry. After
placement in a scintillation vial, the membranes were
dissolved in 1 ml of 2-methoxyethanol, and to each vial
10 ml of scintillation cocktail was added (Scinti Verse-
Fisher). The vials were vortexed, allowed to equilibrate
in the dark, and counted in a Packard Tri-Carb beta
scintillation counter. All counts were checked on a sec-
ond scintillation counter, with each sample counted for
30 minutes for minimizing counting error. Statistical
analysis of the experiments was performed using two-
way analysis of variance and the Kruskal-Wallis one-way
analysis of variance by ranks32 as previously described.26
Protease Inhibitor
BABIM (Figure 1) is a synthetic low-molecular-weight
aromatic amidine inhibitor of trypsin-like pro-
teases.22'3334 The compound's purity has been verified
both by nuclear magnetic resonance spectrometry and
elemental analysis.35 It has previously been shown to
block respiratory syncytial virus-induced cytopathol-
ogy36.37 and inhibit plaque formation, as well as to re-
duce cell injury in Rickettsia ricketsii infections.38 This
compound has an inhibitory effect on trypsin (Ki =
0.017 ± 0.006 iM), urokinase (Ki = 2.33 ± 0.36 gM),
thrombin (Ki = 4.15 ± 0.65 rM), and plasmin (Ki =
2.65 ± 0.47 gM), though this may not be the cause of
its antimicrobial effect.37
In Vivo Experiments and Tumor Transplantation
Athymic (nude) virgin mice of the NIH I BALB/
c/NIH Swiss hybrid (T-cell-deficient) strain39 were bred
and maintained in the Athymic Mouse Isolation Facil-
ity of the University of North Carolina at Chapel Hill.
This facility meets or exceeds the legal standards of an-
imal care and use established under federal laws and
the policies on animal welfare published in the NIH
guide for contracts and grants. Adult females were in-
oculated with varying doses of HT-1080 cells suspended
in serum-free DMEM at a concentration of 1 x 106
cells/0.1 ml. We injected cells either subcutaneously into
the right inguinal region to produce flank tumors and
to measure "spontaneous" metastases or intrajugularly
to quantitate "experimental" metastases. Animals re-
ceiving intrajugular injections were anesthetized with
a 1:1 mixture of acepromazine maleate and ketamine hy-
drochloride at a concentration of 0.03 ml/30 g mouse for
surgical exposure of the internal jugular vein. Six
animals received flank or intravenous injections of ve-
hicle only.
After 3 weeks, half of the tumor cell-injected animals
were observed to have evidence of tumors and were hu-
manely sacrificed along with an appropriate number
of control animals. A gross necropsy was immediately
performed, and selected tissues were removed and fixed
in 10070 buffered formalin for light-microscopic study.
Tissues studied histologically included the right ingui-
nal lymph node, flank tumor, and associated skin or
AJP * April 1986
INHIBITION OF INVASION BY BABIM 49




Figure 1 -The chemical structure of the synthetic low-molecular-weight
aromatic amidine inhibitor BABIM. A coupling of the parent compound
5(6)-amidinobenzimidazole with itself across a carbon bridge resulted in
a 100-fold increase in potency. In its natural state the compound will prob-
ably not be linear but rather will form hydrogen bonds between the Ni and
N3' nitrogen of the imidazole groups, transformingjhe compound into a
5-ring structure.
muscle if the tumor was fixed to tissue, liver, kidney,
spleen, and heart/lung as one block. The lung was
prefixed by an infusion of Bouin's fluid through the tra-
chea prior to removal to aid in identification of
metastatic foci. Excess Bouin's fluid was removed by
multiple exchanges in 70% alcohol prior to embedding
in paraffin. Remaining animals were allowed to survive
and sacrificed as tumors became evident.
Tumor tissue from a primary flank mass having
reached a size of approximately 2 x 1 x 1 cm was re-
moved from a sacrificed animal. The tumor was minced
into fragments <1 mm in size. They were placed in Petri
dishes containing DMEM supplemented with 100%o fe-
tal bovine serum, and antibiotics and were allowed to
grow out. The cells grew rapidly; and after 4 days cells,
one to several layers thick, covered the dishes and were
passaged. The resulting cells.had a phenotypic appear-
ance identical to the original HT-1080 cells and were
then used in a repeat invasion assay in the presence or
absence of 10-4 M BABIM.
Measurement of Type IV Collagenase
HT-1080 tumor cells (1 x 105) were suspended in
serum-free medium containing antibiotics and seeded
into triplicate wells for 72 hours in the presence or ab-
sence of 10- M BABIM. There was no qualitative differ-
ence in cell growth between the different groups. The
secreted Type IV collagen-degrading metalloprotease
activity was determined in an appropriate aliquot as
described by Liotta et al,5'20 as modified by us,26 except
that tritiated, rather than 14C-proline-labeled Type IV
collagen was used as substrate (a gift from Dr. T.
Turpeenniemi-Hujanen). Latent enzyme was activated
by 0.01To trypsin for 5 minutes at 37 C, and the reaction
was assayed in the presence of a five fold-concentrated
solution of soybean trypsin inhibitor and 3.8 mM N-
ethylmaleimide. The reaction was terminated after 18
hours, by cooling to 4 C for 10 minutes with the addition
of BSA, followed by trichloroacetic acid (1007e)/tannic
acid (0.5%) precipitation, in the presence of 2 mM L-
proline, for 90 minutes at 4 C. The samples were cen-
trifuged, and the supernatants were counted in a Pack-
ard B-scintillation counter. Bacterial collagenase (Sigma
Chemical Company) was used as a positive control. Par-
allel control samples were treated with 15 mm EDTA
to verify the metalloproteinase nature of the affected
enzymes. The data are expressed as radioactivity (counts
per minute) solubilized per 105 cells per 18 hours and
as a percentage of the maximal degradation by bacterial
collagenase in untreated controls which were fixed at
100%. Triplicates were performed, the experiment was
repeated twice, and results were expressed as means ±
the standard deviations. The results were subjected to
the Student t test for comparison of means.32 The lin-
ear range of the assay has previously been determined
to be between 0% and 60% of the maximum substrate
degraded by bacterial collagenase.17
Results
Invasion of HT-1080 Cells Through the Amnion
One hundred to five hundred thousand viable cells
per invasion chamber were layered on the epithelial
denuded amniotic basement membrane (BM) at the
start of each experiment. Although tumor cells can in-
vade across epithelial and endothelial cell-covered base-
ment membranes in in vitro assays,25 denuding the epi-
thelial layer provided for a more reproducibly uniform
surface and negated the potential problem of partial
surface denudation during processing and handling as
accounting for observed changes. During the first 24
hours the cells were in a DMEM supplemented with
10% fetal bovine serum to enhance attachment of the
cells to the BM. At 24 hours the serum-containing
medium was withdrawn from the cells and the experi-
ments begun in serum-free medium. As was observed
in other studies using this system, only a minor popu-
lation of the total exposed cells were able to cross the
membrane (<1%), become entrapped in the underly-
ing filter, and remain viable for counting purposes (Fig-
ure 2 [inset]).24'26 Of those cells eventually crossing the
amnion, the majority (>60%) did so during the first
48 hours. The total number of cells that passed through
varied greatly between experiments, thereby necessitat-
ing the use of a single amnion for any one set of ex-
periments, the random selection of chambers to be
divided into treated and nontreated groups, and per-
formance of all experiments in triplicate. It was for these
reasons that we chose to express our results below as
percent inhibition rather than number of cells crossing
onto the filter. Because the HT-1080 fibrosarcoma cells
are fully transformed in culture, they do not show con-
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tact inhibition, but rather rapidly attach, cover the base-
ment membrane-exposed surface, and proliferate, cover-
ing the surface with a multinumbered layer(s) of cells
(Figure 2). This prevented accurate cell counts of tu-
mor cell covered amnions. In all experiments reported
the membrane was judged by scanning power (40x)
viewing, to be covered in an equivalent manner in both
experimental and control groups, or was excluded from
the study.
For the first series of experiments, the effect of
BABIM on in vitro invasion of HT-1080 cells was stud-
ied. These cells are one of a large number of mesen-
chymal-derived malignant cells successfully propagated
in tissue culture which invade in the amnion system.
BABIM has a molecular weight of approximately 300
and is a bicyclic amidino-substituted heterocyclic com-
pound which strongly inhibits trypsin, plasmin, and
urokinase-induced plasminogen activation.22,35-38
At Day 3 of exposure to a molar concentration of
10-4 BABIM, the cells demonstrated a mean inhibition
of 27.8 We as compared with the untreated controls. Cells
were inhibited 460/, a highly significant finding (P <
0.005), when compared with untreated cells by Day 7
(1850o inhibition by the method of Thorgeirsson17).
This concentration of BABIM was initially selected be-
cause it has previously been shown to have a low de-
gree of cytotoxicity in animal models in which it was
studied.35'38
Because of the tedious nature (>2 hours/filter) of
counting each Millipore filter at 400 diameters with a
standard light microscope, we considered biosyntheti-
cally labeling the whole amninon with L-(U14-C)-proline,
in the presence of ascorbic acid and beta-aminopropi-
onitrile in proline/glutamine-free DMEM supplemented
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Figure 2-Photomicrograph of the
mat of multilayered HT-1080 cells
on the amnion basement mem-
brane. The tumor cells were ex-
posed to 10-4 M BABIM for 7 days
in serum-free medium after an ini-
tial 24 hours in 10% fetal bovine
serum-containing media to en-
hance attachment. (Hematoxylin,
original magnification, x 250)
Insert-Representative field of
HT-1080 cells which successfully
crossed the amnion and were
trapped on the underlying methyl
cellulose filter. (Hematoxylin, origi-
nal magnification, x 250)
with 200/0 dialyzed fetal calf serum, as has previously
been suggested.24 We found the variation of intensity
of the label too great within a single amnion to be re-
producible in our hands. Therefore, we elected to label
the rapidly growing individual HT-1080 cell's DNA with
3H-thymidine and measure the counts on the filter.
12
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Figure 3-Demonstration of the linear relationship between tritiated counts
per minute and numbers of cells on methyl cellulose filters. HT-1 080 cells
were grown for 24 hours in the presence of methyl-3H-thymidine; and af-
ter trypsinization and washing, numbers of cells were counted and known
amounts added to methyl cellulose filters. The points represent the mean
of triplicate samples. The correlation coefficient of the line is 0.997.
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Measuring Tritiated Thymidine-Labeled Cells
Figure 3 demonstrates the linear relationship which
existed between the number of cells on the Millipore
filter and the amount of radioactivity on the same filter.
When duplicate experiments were performed with one
set being counted microscopically and the other by
scintillation counting for 30 minutes to minimize the
standard error, the results were as shown in Figure 4.
Within the range of experimental error, the percent in-
hibition of invasion was identical by both methods.
By this radiolabeling technique the maximum per-
cent inhibition of invasion of viable tumor cells after
3 days of exposure to BABIM was between 59.1Wo and
76.4%, across a 2 orders of magnitude change in the
molar concentration of BABIM in serum-free medium,
as is demonstrated in Figure 5. At all three concentra-
tions there was no difference in the cells' ability to at-
tach to the BM and remain viable. However, unexpect-
edly, although the percent reduction of invasive cells
increased by Day 7 in the cells treated with 10-4 M, the
difference between the treated and control groups dis-
appeared by Day 7 in the cells treated with either 10-3
or 10-5 M BABIM (data not shown). This does not ne-
gate the fact that, for example, in 10-3M BABIM-treated
cells, two-way analysis of variance demonstrated a time
effect (P < 0.005), a treatment effect (P < 0.005), and
a time treatment interaction (P < 0.01) for the treated
versus nontreated cellular populations.
In order to assess the minimal effective inhibitory
dose, cells were exposed to BABIM at a concentration
from 10-3 to 10-24 M. At concentrations of 10-6 M or
less there was no difference in inhibitory effect of



















Figure 4-A histogram of the percent inhibition of invasion of HT-1 080 cells
in the presence of 10-4 M BABIM as compared with untreated cellular con-
trols exposed to the identical amnionic membrane. BABIM-containing medi-
um was replaced every other day. The hatched boxes represent the mean
differences based on visual observation, and the solid bars are determi-
nations based on beta scintillation counting. By the analysis of variance
test for a two by three factorial experiment replicated three times, for the
visually counted cells the results were highly significant (time effect, P <
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MOLAR CONCENTRATION OF BABIM
IN MEDIUM
Figure 5-Maximal inhibition of invasion obtained after 3 days of exposure
to serum-containing medium with from 10-3 to 10-5 M BABIM. For 10-5 M
treatment as an example, the actual mean counts per minute were 736.6
for the control and 173.8 in the BABIM treated group. This corresponds
to 5402 and 1275 cells, respectively. At each concentration tested the in-
hibition was highly significant.
still significant inhibition at concentrations diluted to
between 10-9 and 10`o M. A representative chart of in-
hibition between 10-3M and 10-24 M is shown in Table 1.
Growth Kinetics of BABIM-Treated HT-1080 Cells
In order to exclude the possibility that the observed
differences in treated and untreated cell populations
were due to inhibition of cell growth in the presence
of BABIM, growth curves of the cells were performed.
As is seen in Figure 6A, multiple cultures of cells were
plated at Day 0 in the presence of 100o fetal bovine se-
rum, mimicking the conditions of the upper amnion
invasion assay chamber. At Day 1 (arrow), the serum-
containing medium was withdrawn, and the mean cell
count, in the presence and absence of 10-4 M BABIM
was quantitated. There was a small decrease in the to-
tal number of cells during the next 2 days, with the cells
entering the log phase of growth between the fifth and
seventh days. There was no significant difference dur-
ing the early part of the experiment (for example, Day
3, where invasion inhibition was maximal). However,
by Day 7, there was observed a 44% decrease in the cell
count, closely paralleling the differences in invasive
capability. Because the upper and lower chambers per-
mit free diffusion of macromolecules, it was decided
to repeat the cell growth curves in the presence of 10%
fetal bovine serum (a normal constituent of the lower
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52 CRESSON ET AL
Table 1-Effect of Varying Concentrations of BABIM on the
















* Mean % inhibition (n = 4) of tumor invasion through amnion at 72
hours. See text for details.
t At very low concentrations some wells show a small stimulatory effect
(<30%) as compared with treated cells, probably representing biologic
variability in the system.
compartment). As is seen in Figure 6B, the cell kinetics
across the seven days were now virtually identical. It
thus appears that BABIM has no effect on cell growth
of kinetics at the time when inhibition of invasion by
HT-1080 cells is at its maximum.
In Vivo Experiments
Even though this line has been shown by others to
grow in nude mice,29 we repeated the experiments to
verify the tumorigenic and metastatic nature of the cell
line.39 NIH-Swiss mice were treated with varying doses
of HT-1080 cells by subcutaneous flank injection, for
measurement of "spontaneous" metastasis and via in-
trajugular injection for measurement of "experimen-
tal metastasis."'4'4 Those mice receiving the largest dose
by either route (2 x 106 cells) acquired local tumor
growth and visceral metastases, including regional
lymph node and adrenal gland involvement by the
subcutaneous route and periarterial intrapulmonary
metastases by the intravascular route, after 3 weeks (Fig-
ure 7). Additional animals continued to develop tumors
and were sacrificed as the tumor burden became life-
threatening. None of the controls showed spontaneous
tumor development.
Cells from a primary flank mass were returned to tis-
sue culture, passaged, and placed into amnion invasion
assay chambers. An order of magnitude greater num-
ber of cells were able to cross the basement membrane
than we have previously or subsequently seen in simi-
larly run experiments. Quite unexpectedly, although the
inhibition, by 10-4 M BABIM, at Day 3 was 52.5%7 (a
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Figure 6-Kinetics of cell growth, at 37 C in 5% C02/95°/ air, in the ab-
sence (A) or presence (B) of a 10% fetal bovine serum supplemented in
Dulbecco's minimal essential medium. (0), HT-1 080 cells without BABIM
exposure; (0), identical cells exposed to 10-4 M BABIM for 7 days. The
medium was replaced every other day. Each point represents the mean
of triplicates. In A the correlation coefficients were 0.89 and 0.96 (not sig-
nificant), and in B the correlation coefficients were 0.995 and 0.945 (not
significant).
initial nonpassaged cells), by Day 7 the difference be-
tween the treated and nontreated groups was 75.2%
(403%7 inhibition by the method of Thorgeirsson), a
number in the range of maximal inhibition seen at other
treatment dosages at Day 3 (Figure 5).
Type IV Collagen Degrading Activity
In order to verify that, in this model system, BABIM
inhibits proteases in general, and proteases which de-
grade basement membrane proteins in particular, we
assessed the HT-1080 fibrosarcoma cell's ability to se-
crete Type IV collagenase in the presence or absence
of BABIM. As is shown in Table 2, at the time of maxi-
mum tumor invasion (3 days) BABIM inhibits col-
lagenase activity by 44% (P < 0.005). Repeat experi-
ments (data not shown) yielded similarly significant
changes in inhibition of Type IV collagenase in the pres-
ence of BABIM. This lends further strength to the
Figure 7A-Low-power photomicrograph of HT-1080 cells growing in the lower dermis of the flank of a nude female mouse given an injection at that
same site of 2 x 106 cells in 0.1 ml medium vehicle 3 weeks earlier. Note the apparent circumscription of the tumor and the noninvolvement of the
overlying epidermis. (H&E; original magnification, x 40). B-Metastatic focus of fibrosarcoma cells well seen in the subcapsular sinus (upper center)
of the right inguinal lymph node draining the primary tumor focus. Tumor cells are admixed with histiocytelike reticular cells in the nodal parenchyma.
One island of lymphocytes (lower right) is also appreciated. (H&E; original magnification, x40) C-Two foci of intrapulmonary metastases from a
BALB/c/NIH-Swiss hybrid mouse given 1 x 106 cells by left intrajugular injection. One focus (upper) has an intraalveolar distribution, and the lower
one is clearly seen expanding a peribronchial artery. (H&E; original magnification, x 40) D-Nest of tumor cells within an alveolar space seen at
higher power to demonstrate cellular detail. (H&E; original magnification, x 250)
.-
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Table 2-Type IV Collagenolytic Activity in the Culture Fluid
of HT-1080 Cells in the Presence or Absence of BABIM
Type IV collagenase
Treatment* CPM/105 cells/18H activity (mean %)
HT-1080 cells alone 1423.1 + 44.3t 47.0
HT-1080 + 10-4M 792.6 ± 87.1 26.1
BABIM
HT-1080 + bacterial 3024.7 ± 4.2 100.0
collagenase
HT-1080 + bacterial 3021.7 ± 4.2 99.9
collagenase +
BABIM
* See text for details.
t Mean of triplicate samples + standard deviation.
argument that there is a correlation between Type IV
collagenase levels in extracellular supernatants and in-
vasiveness, as monitored by the amnion system, as we26
and others50 have previously suggested. Naturally, this
does not exclude the possibility that other mechanisms
and/or other proteases might operate in this system.
Additionally, since BABIM is a potent inhibitor of the
active site on trypsin, these types of experiments do not
totally exclude the possibility that the trypsin activa-
tion of Type IV collagenase is influenced by competi-
tion from BABIM. Experiments to exclude this possi-
bility are currently being planned.
Discussion
There is a large amount of experimental evidence that
suggests that tumor invasion is a multistep process.42
Invasion, in turn, is one link in the metastatic cascade.43
A second series of physiologic events, the fibrinolytic
cascade, has also been associated with malignancy and
metastasis.44 Chief among the suspected products is
plasminogen activator(s) (PA).45 PAs are a group of
closely related serine proteases which have been linked,
in both animal and human primary tumors and cell lines
to metastatic ability and tumor invasion. However, not
all studies demonstrate such a correlation.7-946 Al-
though the exact role that PA plays in invasion is not
entirely clear, it is known that PA modulates the acti-
vation of plasminogen to plasmin. Plasmin, in turn,
can, in a feedback loop, stimulate PA47 as well as de-
grade fibronectin and laminin, the major noncolla-
genous glycoprotein component of BM, thereby play-
ing a central role in extracellular matrix remodeling.448
Plasmin has also been shown to activate both vertebral
collagenase I, II, and III, thereby allowing degradation
of interstitial collagens,49 and latent BM (Type IV) col-
lagenase. This is a potentially critical step in invasion,
because levels of activated Type IV collagenase have
been directly linked to metastatic potential in malig-
nant cells in vitro and in vivo.5*50
In these studies we have elected to measure the in-
hibitory effect of BABIM on HT-1080 human fibrosar-
coma cells with the use of a quantitative in vitro inva-
sion system. This assay, which uses human amnion from
normal term placentas, overcomes many previously
defined deficiencies in in vitro models.5152 Advantages
include 1) the absence of a complicating nervous, vas-
cular, lymphatic or immune system and 2) the lack of
dependence upon nonhuman or artificial matrices. Fur-
thermore, 3) it contains no contaminating host inflam-
matory cells, 4) is not dependent on the life cycle of
the host, 5) can be used to quantify the passed cells,
and 6) is relatively inexpensive and readily available.
Its greatest advantage, however, is that invasion through
the amnion is a relatively accurate predictor of the cell
population's invasive capacity in vivo, due to its corre-
lation with enzymatic degradation of basement mem-
brane collagen.25 26.50
HT-1080 fibrosarcoma cells were chosen in these ex-
periments for a number of critical reasons. This line
has been shown to produce BM proteins53 and both high
PA and elevated Type IV collagenase levels in both tryp-
sin activated and nonactivated forms.6 It has also been
shown to have the ability to degrade extracellular ma-
trices in a density-dependent manner.54 Furthermore,
an endothelial cell factor could be shown to inhibit this
degrading ability by inhibiting the production of tu-
mor cell plasminogen activators, in a nondirect man-
ner." It therefore seemed prudent to study the effects
of BABIM on HT-1080, because it is known to interact
at several points along the fibrinolytic pathway, which,
when normally functioning, leads to the activation of
cellular collagenolytic metalloproteases.
Our data have led us to draw the following inferences
and conclusions. First, BABIM, at a concentration of
from 10-9 to 10-3 M, inhibits the ability of HT-1080 cells
to invade BM, as judged by the amnion invasion assay.
This inhibitory effect at very low concentrations fur-
thermore suggests a very specific receptor ligand type
interaction. Second, at the concentrations of from 10-5
to 10-3 M this inhibition is highly significant for time
and treatment effect. Third, this can be quantitated in
this sytem equally well by visually counting individual
cells or by 3H-labeling cellular DNA. Fourth, this inhi-
bition of invasive ability is maximal at early times af-
ter exposure to BM. However, this is not the case for
cells derived from tumors passaged in nude mice, where
maximal inhibition is seen at the distant time point.
Fifth, the mechanism of action of the antiinvasive effect
on human fibrosarcoma cells is, at least in part, sec-
ondary to the inhibition of the secretion of Type IV
collagenase.
We have limited these studies to one facet of tumor
invasion, recognizing that other forms of cellular pro-
teinases do have an important role in promoting tumor
invasion. The cathepsin-B-like cystein proteinases have
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previously been shown to have an impact on a cell popu-
lation's invasive and metastatic potential.56 57 These en-
zymes may cooperate with the collagenases in creating
defects in extracellular matrices allowing for cell inva-
sion.58 They are also probably inhibited by BABIM-like
inhibitors. In addition to protein destruction, heparan
sulfate degradation of matrices by heparan sulfate en-
doglycosidase has also been described.59 60 Furthermore,
other events may be critical, such as motility of tumor
cells, in invasive processes.61 Our work does, however,
strongly argue that inhibition of esteroproteases, at least
in this sarcoma line, will retard invasion to a significant
degree. The maximal inhibition of approximately 75'7o,
and no greater, would also support the contention that
other factors influence a cell's ability to invade. Recently,
evidence has been presented which suggests that there
is a threshold level of PA production over which meta-
static ability rises dramatically.62 We are currently test-
ing the ability of BABIM to inhibit metastasis in vivo.
This, we hope, will give us additional evidence to sup-
port or refute this contention.
The human amnion invasion assay serves as an im-
portant system for quantitating a highly complex bio-
logic process. The small percentage of cells able to cross
the BM is similar to that seen in in vivo studies and
is most likely a function of tumor cell heterogeneity.63
By having minimal to no proliferative changes in the
presence of inhibition of invasion, this work lends fur-
ther support to the data suggesting that only protein
synthesis, and not DNA synthesis, is needed for inva-
sion.64'65 We are therefore intrigued by the notion that
within a population of neoplastic cells, a subset of cells
fully capable of invasion, and by extension, metasta-
sis, may not be dependent upon cell proliferation.
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